Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b studyJuly 11, 2023Psoriatic Arthritis
Mental health questions cut from MD licensing applications in 21 statesJuly 10, 2023Business of Medicine
In-office infusions at risk with new Medicare Part B reimbursement recommendationJuly 6, 2023Business of Medicine
New guidelines for MTX use in pediatric inflammatory skin disease unveiledJuly 5, 2023PediatricsLupus & Connective Tissue Diseases
The invisible effect medical notes could have on careJuly 3, 2023Diversity in MedicineBusiness of Medicine
